Boender, Arjen J. 
; Boon, Marina ; Albers, H. Elliott ; Eck, Samantha R. ; Fricker, Brandon A. ; Kelly, Aubrey M. ; LeDoux, Joseph E. ; Shrestha, Prerana ; Taylor, Jack H. ; Trainor, Brian C. ; Triana-Del Rio, Rodrigo ; Young, Larry J. ; Motta, Simone Cristina
Fonte: Science Advances. Unidade: ICB
Assuntos: ANATOMIA, ROEDORES, OCITOCINA, TOXICIDADE EM ANIMAL, NEUROCIÊNCIAS, DISSECAÇÃO ANIMAL, MODELOS ANIMAIS DE DOENÇAS, CIRCUITOS ELETRÔNICOS, GENÔMICA, GENÉTICA BACTERIANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOENDER, Arjen J. et al. An AAV-CRISPR/Cas9 strategy for gene editing across divergent rodent species: Targeting neural oxytocin receptors as a proof of concept. Science Advances, v. 9, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.1126/sciadv.adf4950. Acesso em: 05 nov. 2024.APA
Boender, A. J., Boon, M., Albers, H. E., Eck, S. R., Fricker, B. A., Kelly, A. M., et al. (2023). An AAV-CRISPR/Cas9 strategy for gene editing across divergent rodent species: Targeting neural oxytocin receptors as a proof of concept. Science Advances, 9, 1-16. doi:10.1126/sciadv.adf4950NLM
Boender AJ, Boon M, Albers HE, Eck SR, Fricker BA, Kelly AM, LeDoux JE, Shrestha P, Taylor JH, Trainor BC, Triana-Del Rio R, Young LJ, Motta SC. An AAV-CRISPR/Cas9 strategy for gene editing across divergent rodent species: Targeting neural oxytocin receptors as a proof of concept [Internet]. Science Advances. 2023 ; 9 1-16.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1126/sciadv.adf4950Vancouver
Boender AJ, Boon M, Albers HE, Eck SR, Fricker BA, Kelly AM, LeDoux JE, Shrestha P, Taylor JH, Trainor BC, Triana-Del Rio R, Young LJ, Motta SC. An AAV-CRISPR/Cas9 strategy for gene editing across divergent rodent species: Targeting neural oxytocin receptors as a proof of concept [Internet]. Science Advances. 2023 ; 9 1-16.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1126/sciadv.adf4950
